HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression

Oncogene

Volumn 30, Issue 23, 2011, Pages 2633-2643

  Li, Y ^a   Bavarva, J H ^a   Wang, Z ^a   Guo, J ^a   Qian, C ^a,b   Thibodeau, S N ^b   Golemis, E A ^c   Liu, W ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

colorectal cancer; HEF1; tumorigenesis; Wnt signaling

Indexed keywords

BETA CATENIN; DISHEVELLED 2; MESSENGER RNA; PROTEIN HUMAN ENHANCER OF FILAMENTATION 1; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; WNT3A PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; COLON CARCINOGENESIS; COLON POLYP; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BETA CATENIN; BLOTTING, WESTERN; CACO-2 CELLS; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; COLON; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS; WNT PROTEINS;

MUS;

EID: 79958244521     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.632     Document Type: Article

References (45)

1. Aarskog NK, Vedeler CA. (2000). Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies. Hum Genet 107: 494-498. (Pubitemid 32000420)
2. Barker N, Clevers H. (2006). Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 5: 997-1014. (Pubitemid 44835127)
3. Batistatou A, Charalabopoulos AK, Scopa CD, Nakanishi Y, Kappas A, Hirohashi S et al. (2006). Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma. Virchows Arch 448: 763-767. (Pubitemid 43824433)
4. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R et al. (1996). Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382: 638-642. (Pubitemid 26268958)
5. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP et al. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122: 947-956. (Pubitemid 41345211)
6. Donninger H, Bonome T, Radonovich M, Pise-Masison CA, Brady J, Shih JH et al. (2004). Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways. Oncogene 23: 8065-8077. (Pubitemid 39531847)
7. Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garrett E et al. (2003). beta-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res 63: 3145-3153. (Pubitemid 36735866)
8. Easwaran V, Pishvaian M, Salimuddin, Byers S. (1999). Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways. Curr Biol 9: 1415-1418.
9. Faivre EJ, Lange CA. (2007). Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells. Mol Cell Biol 27: 466-480. (Pubitemid 46080117)
10. Fashena SJ, Einarson MB, O'eill GM, Patriotis C, Golemis EA. (2002). Dissection of HEF1-dependent functions in motility and transcriptional regulation. J Cell Sci 115: 99-111. (Pubitemid 34105533)
11. Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH et al. (2009). A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts meta-static potential. Gastroenterology 137: 165-175.
12. Fujino H, West KA, Regan JW. (2002). Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. J Biol Chem 277: 2614-2619. (Pubitemid 34953286)
13. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT et al. (1998). Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512. (Pubitemid 28425575)
14. Izumchenko E, Singh MK, Plotnikova OV, Tikhmyanova N, Little JL, Serebriiskii IG et al. (2009). NEDD9 promotes oncogenic signaling in mammary tumor development. Cancer Res 69: 7198-7206.
15. Ji H, Ramsey MR, Hayes DN, Fan C, McNamara K, Kozlowski P et al. (2007). LKB1 modulates lung cancer differentiation and metastasis. Nature 448: 807-810. (Pubitemid 47266337)
16. Kim M, Gans JD, Nogueira C, Wang A, Paik JH, Feng B et al. (2006). Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 125: 1269-1281. (Pubitemid 43949521)
17. Kim PJ, Plescia J, Clevers H, Fearon ER, Altieri DC. (2003). Survivin and molecular pathogenesis of colorectal cancer. Lancet 362: 205-209. (Pubitemid 36859937)
18. Labbe E, Letamendia A, Attisano L. (2000). Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci USA 97: 8358-8363. (Pubitemid 30639677)
19. Law SF, O'eill GM, Fashena SJ, Einarson MB, Golemis EA. (2000). The docking protein HEF1 is an apoptotic mediator at focal adhesion sites. Mol Cell Biol 20: 5184-5195. (Pubitemid 30431571)
20. Leone A, Flatow U, VanHoutte K, Steeg PS. (1993). Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 8: 2325-2333. (Pubitemid 23252360)
21. Letamendia A, Labbe E, Attisano L. (2001). Transcriptional regulation by Smads: crosstalk between the TGF-beta and Wnt pathways. J Bone Joint Surg Am 83-A(Suppl 1): S31-S39.
22. Li YC, Park MJ, Ye SK, Kim CW, Kim YN. (2006). Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. Am J Pathol 168: 1107-1118; quiz 1404-1405.
23. Liu T, Li R, Pan T, Liu D, Petersen RB, Wong BS et al. (2002). Intercellular transfer of the cellular prion protein. J Biol Chem 277: 47671-47678. (Pubitemid 36159289)
24. Liu W, Dong X, Mai M, Seelan RS, Taniguchi K, Krishnadath KK et al. (2000). Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet 26: 146-147.
25. Lu D, Cottam HB, Corr M, Carson DA. (2005). Repression of beta-catenin function in malignant cells by nonsteroidal antiinflamma-tory drugs. Proc Natl Acad Sci USA 102: 18567-18571. (Pubitemid 43011266)
26. Lucas Jr JT, Salimath BP, Slomiany MG, Rosenzweig SA. (2010). Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent. Oncogene 29: 4449-4459.
27. Ma H, Nguyen C, Lee KS, Kahn M. (2005). Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression. Oncogene 24: 3619-3631. (Pubitemid 40756231)
28. Merrill RA, See AW, Wertheim ML, Clagett-Dame M. (2004). Crk-associated substrate (Cas) family member, NEDD9, is regulated in human neuroblastoma cells and in the embryonic hindbrain by all-trans retinoic acid. Dev Dyn 231: 564-575. (Pubitemid 39410890)
29. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B et al. (1997). Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790. (Pubitemid 27136715)
30. Natarajan M, Stewart JE, Golemis EA, Pugacheva EN, Alexandro-poulos K, Cox BD et al. (2006). HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene 25: 1721-1732.
31. Novak A, Dedhar S. (1999). Signaling through beta-catenin and Lef/ Tcf. Cell Mol Life Sci 56: 523-537. (Pubitemid 29520839)
32. O'Neill GM, Fashena SJ, Golemis EA. (2000). Integrin signalling: a new Cas(t) of characters enters the stage. Trends Cell Biol 10: 111-119. (Pubitemid 30110694)
33. Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB. (2002). Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 277: 5209-5218. (Pubitemid 34968565)
34. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T et al. (2000). AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24: 245-250. (Pubitemid 30132191)
35. Segditsas S, Tomlinson I. (2006). Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 25: 7531-7537. (Pubitemid 44885752)
36. Shao J, Jung C, Liu C, Sheng H. (2005). Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. J Biol Chem 280: 26565-26572. (Pubitemid 41022254)
37. Spencer VA, Sun JM, Li L, Davie JR. (2003). Chromatin immuno-precipitation: a tool for studying histone acetylation and transcription factor binding. Methods 31: 67-75. (Pubitemid 36945172)
38. Tetsu O, McCormick F. (1999). Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426. (Pubitemid 29180374)
39. van Seventer GA, Salmen HJ, Law SF, O'Neill GM, Mullen MM, Franz AM et al. (2001). Focal adhesion kinase regulates beta1 integrin-dependent T cell migration through an HEF1 effector pathway. Eur J Immunol 31: 1417-1427. (Pubitemid 32454689)
40. Velmurugan B, Singh RP, Kaul N, Agarwal R, Agarwal C. (2010). Dietary feeding of grape seed extract prevents intestinal tumorigen-esis in APCmin/+ mice. Neoplasia 12: 95-102.
41. Xia D, Holla VR, Wang D, Menter DG, DuBois RN. (2010). HEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cells. Cancer Res 70: 824-831.
42. Yasuhara R, Yuasa T, Williams JA, Byers SW, Shah S, Pacifici M et al (2009). Wnt/beta-catenin and retinoic acid receptor signaling pathways interact to regulate chondrocyte function and matrix turnover. J Biol Chem 285: 317-327.
43. Yook JI, Li XY, Ota I, Hu C, Kim HS, Kim NH et al. (2006). A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol 8: 1398-1406. (Pubitemid 44835115)
44. Zhai Y, Wu R, Schwartz DR, Darrah D, Reed H, Kolligs FT et al. (2002). Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas. Am J Pathol 160: 1229-1238. (Pubitemid 34411627)
45. Zheng M, McKeown-Longo PJ. (2002). Regulation of HEF1 expression and phosphorylation by TGF-beta 1 and cell adhesion. J Biol Chem 277: 39599-39608. (Pubitemid 35190940)